Market Research Logo

Fresenius Kabi AG - Strategic SWOT Analysis Review

Fresenius Kabi AG - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and clinical nutrition products. It covers therapeutic areas such as blood volume substitution, fluid management, anesthesia, critical illness, liver insufficiency, renal insufficiency, maldigestion or malabsorption, diabetes mellitus and pediatrics. Its products and services are used for the treatment of critically and chronically ill patients. Fresenius Kabi conducts sales and marketing operations through direct offices worldwide. The company has its facilities in Europe, North America, Latin America, Asia Pacific and Africa. Fresenius Kabi is headquartered in Bad Homburg, Germany.

Fresenius Kabi AG Key Recent Developments

Jun 22,2018: Fresenius Kabi UK expands operations in Runcorn, England
Jun 01,2018: Fresenius Kabi opens new laboratory and office areas at its Innovation & Development Center in Graz, Austria
May 28,2018: New EU Commission’s initiative “SPC manufacturing waiver”
Apr 20,2018: Fresenius Kabi expands production site for medical devices in Dominican Republic
Feb 26,2018: Fresenius remains on growth course after 14 straight record years

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
    • Note: Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
Fresenius Kabi AG - Key Facts
Fresenius Kabi AG - Key Employees
Fresenius Kabi AG - Key Employee Biographies
Fresenius Kabi AG - Major Products and Services
Fresenius Kabi AG - History
Fresenius Kabi AG - Company Statement
Fresenius Kabi AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Fresenius Kabi AG - Business Description
Business Segment: Clinical Nutrition
Overview
Business Segment: Clinical Nutrition Products
Performance
Business Segment: Infusion Therapy
Overview
Business Segment: Infusion Therapy Products
Performance
Business Segment: IV drugs
Overview
Performance
Key Stats
Business Segment: Medical Devices and Transfusion Technology
Overview
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Latin America/Africa
Performance
Geographical Segment: North America
Performance
Fresenius Kabi AG - Corporate Strategy
Fresenius Kabi AG - SWOT Analysis
SWOT Analysis - Overview
Fresenius Kabi AG - Strengths
Fresenius Kabi AG - Weaknesses
Fresenius Kabi AG - Opportunities
Fresenius Kabi AG - Threats
Fresenius Kabi AG - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2012 to YTD 2018
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2012 to YTD 2018
Fresenius Kabi AG, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jun 22, 2018: Fresenius Kabi UK expands operations in Runcorn, England
Jun 01, 2018: Fresenius Kabi opens new laboratory and office areas at its Innovation & Development Center in Graz, Austria
May 28, 2018: New EU Commission’s initiative “SPC manufacturing waiver”
Apr 20, 2018: Fresenius Kabi expands production site for medical devices in Dominican Republic
Feb 26, 2018: Akorn Issues Statement on Investigation
Feb 26, 2018: Fresenius remains on growth course after 14 straight record years
Jan 29, 2018: HES solutions should remain on the market
Dec 01, 2017: Fresenius Kabi opens extension at production plant in Mihla, eastern Germany
Nov 30, 2017: Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages
Nov 02, 2017: Fresenius reports another strong quarter and confirms guidance
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Fresenius Kabi AG, Key Facts
Fresenius Kabi AG, Key Employees
Fresenius Kabi AG, Key Employee Biographies
Fresenius Kabi AG, Major Products and Services
Fresenius Kabi AG, History
Fresenius Kabi AG, Other Locations
Fresenius Kabi AG, Subsidiaries
Fresenius Kabi AG, Joint Venture
Fresenius Kabi AG, Key Competitors
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2012 to YTD 2018
Fresenius Kabi AG, Medical Equipment, Deals By Type, 2012 to YTD 2018
Fresenius Kabi AG, Recent Deals Summary
List of Figures
Fresenius Kabi AG, Medical Equipment, Deals By Year, 2012 to YTD 2018
Fresenius Kabi AG, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report